The treatment of cardiovascular symptoms of vasomotor origin.
D001533:Belladonna Alkaloids / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D002979:Climacteric; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female / Q000150:complications; D006801:Humans; D009449:Neurocirculatory Asthenia; D010634:Phenobarbital / Q000627:therapeutic use*
D001533:Belladonna Alkaloids; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010634:Phenobarbital
BELLADONNA ALKALOIDS/therapeutic use; CLIMACTERIC, FEMALE/complications; ERGOT ALKALOIDS/therapeutic use; NEUROCIRCULATORY ASTHENIA; PHENOBARBITAL/therapeutic use